These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20413022)

  • 1. Metabolic and hepatobiliary side effects of antiretroviral therapy (ART).
    Lugassy DM; Farmer BM; Nelson LS
    Emerg Med Clin North Am; 2010 May; 28(2):409-19, Table of Contents. PubMed ID: 20413022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Older HIV patients face metabolic complications.
    Greene MD
    Nurse Pract; 2003 Jun; 28(6):17-25; quiz 26-7. PubMed ID: 12796620
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
    Barbaro G
    Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and metabolic abnormalities among HIV-infected patients: a current review.
    Kibirige D; Ssekitoleko R
    Int J STD AIDS; 2013 Aug; 24(8):603-11. PubMed ID: 23970578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
    Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
    Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of human immunodeficiency virus therapy.
    Hayes EV; McGann KA
    Pediatr Infect Dis J; 2004 Sep; 23(9):873-4. PubMed ID: 15361730
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
    Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects of antiretroviral therapy].
    Teodor A; Teodor D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):23-6. PubMed ID: 15688751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweetening the toxic cocktail. Managing the side effects of HIV medications.
    Doerfler RE
    Adv Nurse Pract; 2002 May; 10(5):52-4, 57-8, 103. PubMed ID: 12420531
    [No Abstract]   [Full Text] [Related]  

  • 11. [The side effects of antiretroviral therapy].
    Hartmann M
    Hautarzt; 2006 Nov; 57(11):969-74. PubMed ID: 17036249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
    Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
    Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
    Leonard EG; McComsey GA
    Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?
    Bradbury RA; Samaras K
    Diabetes Obes Metab; 2008 Jun; 10(6):441-50. PubMed ID: 17825081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver toxicity of antiretroviral drugs.
    Jones M; Núñez M
    Semin Liver Dis; 2012 May; 32(2):167-76. PubMed ID: 22760656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipodystrophy and metabolic disturbances as complications of antiretroviral therapy].
    Bociaga-Jasik M; Kieć-Wilk B; Kalinowska-Nowak A; Mach T; Garlicki A
    Przegl Lek; 2010; 67(12):1332-4. PubMed ID: 21591364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving toxicities associated with anti-HIV therapies.
    Bean P
    Am Clin Lab; 2002 May; 21(4):12-5. PubMed ID: 12087632
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
    Ingiliz P; Benhamou Y
    J HIV Ther; 2009 Mar; 14(1):3-7. PubMed ID: 19731558
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection.
    Heath KV; Montaner JS; Bondy G; Singer J; O'Shaughnessy MV; Hogg RS
    Curr Drug Targets; 2003 Jan; 4(1):13-22. PubMed ID: 12528986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of metabolic complications after 10 years of antiretroviral treatment in Senegal].
    Diouf A; Cournil A;
    Bull Soc Pathol Exot; 2014 Oct; 107(4):234-7. PubMed ID: 24683016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.